OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Summary

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

News Radar provides aggregated summaries. Full content and copyright remain with the original publisher.